Tessel Rigter

988 total citations
34 papers, 646 citations indexed

About

Tessel Rigter is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Tessel Rigter has authored 34 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Physiology. Recurrent topics in Tessel Rigter's work include Genomics and Rare Diseases (10 papers), BRCA gene mutations in cancer (9 papers) and Ethics in Clinical Research (8 papers). Tessel Rigter is often cited by papers focused on Genomics and Rare Diseases (10 papers), BRCA gene mutations in cancer (9 papers) and Ethics in Clinical Research (8 papers). Tessel Rigter collaborates with scholars based in Netherlands, Germany and Italy. Tessel Rigter's co-authors include Martina C. Cornel, Stephanie S. Weinreich, Lidewij Henneman, Georg F. Hoffmann, Peter Burgard, Kathrin Rupp, Luciano Vittozzi, J.G. Loeber, Marleen E. Jansen and Domenica Taruscio and has published in prestigious journals such as PLoS ONE, Journal of Medical Internet Research and Frontiers in Pharmacology.

In The Last Decade

Tessel Rigter

29 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tessel Rigter Netherlands 14 276 184 182 117 101 34 646
Laurel K. Willig United States 10 359 1.3× 113 0.6× 55 0.3× 162 1.4× 43 0.4× 14 538
Joannie Hui Hong Kong 16 76 0.3× 89 0.5× 347 1.9× 328 2.8× 30 0.3× 46 739
Julie A. Cakici United States 9 505 1.8× 108 0.6× 67 0.4× 203 1.7× 69 0.7× 12 722
Angelika Erwin United States 12 109 0.4× 231 1.3× 13 0.1× 218 1.9× 35 0.3× 31 646
Xiaomu Kong China 15 102 0.4× 36 0.2× 28 0.2× 240 2.1× 70 0.7× 42 717
E Mayayo Spain 13 53 0.2× 125 0.7× 15 0.1× 97 0.8× 27 0.3× 48 510
Nataša Karas Kuželički Slovenia 14 53 0.2× 150 0.8× 40 0.2× 156 1.3× 194 1.9× 42 489
Abdulrahman Al-Nuaim Saudi Arabia 11 86 0.3× 51 0.3× 22 0.1× 178 1.5× 73 0.7× 24 547
F Bonńici South Africa 13 111 0.4× 61 0.3× 27 0.1× 100 0.9× 58 0.6× 33 627
Ching‐Shan Huang Taiwan 13 31 0.1× 603 3.3× 120 0.7× 314 2.7× 30 0.3× 27 771

Countries citing papers authored by Tessel Rigter

Since Specialization
Citations

This map shows the geographic impact of Tessel Rigter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tessel Rigter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tessel Rigter more than expected).

Fields of papers citing papers by Tessel Rigter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tessel Rigter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tessel Rigter. The network helps show where Tessel Rigter may publish in the future.

Co-authorship network of co-authors of Tessel Rigter

This figure shows the co-authorship network connecting the top 25 collaborators of Tessel Rigter. A scholar is included among the top collaborators of Tessel Rigter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tessel Rigter. Tessel Rigter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jansen, Marleen E., et al.. (2024). Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study. Journal of Medical Internet Research. 26. e47389–e47389. 2 indexed citations
3.
Cornel, Martina C., Karuna R. M. van der Meij, Carla van El, Tessel Rigter, & Lidewij Henneman. (2024). Genetic Screening—Emerging Issues. Genes. 15(5). 581–581. 2 indexed citations
4.
Rigter, Tessel, et al.. (2024). The impact of digital health technologies on moral responsibility: a scoping review. Medicine Health Care and Philosophy. 28(1). 17–31. 2 indexed citations
5.
Jansen, Marleen E., Tessel Rigter, Patrick C. Souverein, et al.. (2023). Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users. Genes. 14(2). 456–456. 2 indexed citations
6.
El, Carla van, Phillis Lakeman, Mariëtte Goddijn, et al.. (2022). Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders. PLoS ONE. 17(6). e0269719–e0269719. 4 indexed citations
7.
Jansen, Marleen E., et al.. (2022). Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different Policies. Frontiers in Genetics. 13. 865799–865799. 6 indexed citations
8.
Vrijenhoek, Terry, Neeme Tõnisson, H Kääriäinen, Liis Leitsalu, & Tessel Rigter. (2021). Clinical genetics in transition—a comparison of genetic services in Estonia, Finland, and the Netherlands. Journal of Community Genetics. 12(2). 277–290. 8 indexed citations
9.
Rigter, Tessel, David J. Klein, Stephanie S. Weinreich, & Martina C. Cornel. (2021). Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe. European Journal of Human Genetics. 29(10). 1477–1484. 6 indexed citations
10.
Graaf, Rieke van der, Tessel Rigter, Eline M. Bunnik, et al.. (2021). Towards a Responsible Transition to Learning Healthcare Systems in Precision Medicine: Ethical Points to Consider. Journal of Personalized Medicine. 11(6). 539–539. 6 indexed citations
11.
Cornel, Martina C., Tessel Rigter, Marleen E. Jansen, & Lidewij Henneman. (2020). Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide. Journal of Community Genetics. 12(2). 257–265. 39 indexed citations
12.
Rigter, Tessel, et al.. (2020). Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective. Frontiers in Genetics. 11. 10–10. 41 indexed citations
13.
Jansen, Marleen E., Tessel Rigter, Wendy Rodenburg, et al.. (2017). Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity. Frontiers in Pharmacology. 8. 555–555. 16 indexed citations
14.
Rigter, Tessel, et al.. (2017). Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape. BMC Health Services Research. 17(1). 146–146. 33 indexed citations
15.
Bell, Jessica, Victoria Coathup, Tessel Rigter, et al.. (2016). Challenges and opportunities for ELSI early career researchers. BMC Medical Ethics. 17(1). 37–37. 7 indexed citations
16.
Houwink, Elisa J. F., Tessel Rigter, Jesse J. Swen, et al.. (2015). [Pharmacogenetics in primary health care: implementation and future expectations].. PubMed. 159. A9204–A9204. 3 indexed citations
17.
Bosma, Astrid, Tessel Rigter, Stephanie S. Weinreich, Martina C. Cornel, & Lidewij Henneman. (2015). A genetic diagnosis of maturity‐onset diabetes of the young (MODY): experiences of patients and family members. Diabetic Medicine. 32(10). 1385–1392. 10 indexed citations
18.
Weinreich, Stephanie S., Astrid Bosma, Tessel Rigter, et al.. (2014). Current and Best Practices of Genetic Testing for Maturity Onset Diabetes of the Young: Views of Professional Experts. Public Health Genomics. 18(1). 52–59. 17 indexed citations
19.
El, Carla van, Tessel Rigter, Arnold Reuser, et al.. (2014). Newborn screening for pompe disease? a qualitative study exploring professional views. BMC Pediatrics. 14(1). 203–203. 11 indexed citations
20.
Cornel, Martina C., Tessel Rigter, Stephanie S. Weinreich, et al.. (2013). A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document. European Journal of Human Genetics. 22(1). 12–17. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurel K. Willig Breakdown of academic impact, for papers by Joannie Hui Breakdown of academic impact, for papers by Julie A. Cakici Breakdown of academic impact, for papers by Angelika Erwin Breakdown of academic impact, for papers by Xiaomu Kong Breakdown of academic impact, for papers by E Mayayo Breakdown of academic impact, for papers by Nataša Karas Kuželički Breakdown of academic impact, for papers by Abdulrahman Al-Nuaim Breakdown of academic impact, for papers by F Bonńici Breakdown of academic impact, for papers by Ching‐Shan Huang
Rankless by CCL
2026